Three series of novel fused nitrogen heterocyclic systems such as 1,2,4-triazolo[1,5-α ] pyridines (5-7 and 9), pyrido[1,2-b][1,2,4]triazines (10, 11, 13 and 15), and pyrido[1,2-b][1,2,4]triazepines (17, 18, 20 and 22) linked with a chromone moiety were synthesized from the key intermediate 1,6-diamino-(6-chloro-4-oxo-4H-chromen-3-yl)-2-oxo-1,2-dihydropyridine-3,5-dicarbonitrile (4) with some electrophilic reagents. The structures of the novel compounds were established by elemental analyses and spectral data. All the products were also screened invitro for their antimicrobial activity. Compounds 7, 9 and 15 showed the highest activities when compared with the reference drugs.

A new series of 2,3-disubstituted-5-oxochromeno[2,3-b]pyridine derivatives has been obtained throughout a 1,8-diazabicyclo[5.4.0]undec-7-ene (DBU)-catalyzed reaction of 4-oxo-4H-chromene-3-carbonitrile with various active methyl and methylene compounds. The Friedländer reaction of 2-amino-4-oxo-4H-chromene-3-carboxaldehyde with the same active methyl and methylene compounds led to the identical products, suggesting that basic catalyzed ring rearrangement took place during the course of reaction.

The synthesis of some new pyrido[1,2-b][1,2,4]triazines (2-12) was achieved by cyclocondensation of 4-aryl-1,6-diamino-2-oxo-1,2-dihydropyridine-3,5-dicarbonitriles (1a, b) with α,β-bifunctional compounds. Pyrido[1,2:2´,3´]triazino[5´,6´-f]triazines (13-14) were also prepared. The behavior of 1a, b toward interactions with indole-2,3-dione and its N-acetyl analogue have been studied under different reaction conditions. The structures of the new products have been deduced from elemental analysis and spectral data (UV, IR, ¹H NMR, 13C NMR and mass spectra). The new synthesized compounds were screened for their antifungal activities.